Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 3
2019 2
2020 2
2021 4
2022 3
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Nanovehicles for co-delivery of anticancer agents.
Zeinali M, Abbaspour-Ravasjani S, Ghorbani M, Babazadeh A, Soltanfam T, Santos AC, Hamishehkar H, Hamblin MR. Zeinali M, et al. Among authors: abbaspour ravasjani s. Drug Discov Today. 2020 Aug;25(8):1416-1430. doi: 10.1016/j.drudis.2020.06.027. Epub 2020 Jul 2. Drug Discov Today. 2020. PMID: 32622880 Review.
CTLA-4: As an Immunosuppressive Immune Checkpoint in Breast Cancer.
Ghahremani Dehbokri S, Alizadeh N, Isazadeh A, Baghbanzadeh A, Abbaspour-Ravasjani S, Hajiasgharzadeh K, Baradaran B. Ghahremani Dehbokri S, et al. Among authors: abbaspour ravasjani s. Curr Mol Med. 2023;23(6):521-526. doi: 10.2174/1566524022666220610094716. Curr Mol Med. 2023. PMID: 35692146 Review.
Nanocarrier-based dermopharmaceutical formulations for the topical management of atopic dermatitis.
Cláudia Paiva-Santos A, Gama M, Peixoto D, Sousa-Oliveira I, Ferreira-Faria I, Zeinali M, Abbaspour-Ravasjani S, Mascarenhas-Melo F, Hamishehkar H, Veiga F. Cláudia Paiva-Santos A, et al. Among authors: abbaspour ravasjani s. Int J Pharm. 2022 Apr 25;618:121656. doi: 10.1016/j.ijpharm.2022.121656. Epub 2022 Mar 9. Int J Pharm. 2022. PMID: 35278601 Free article. Review.
CDX-modified chitosan nanoparticles remarkably reduce therapeutic dose of fingolimod in the EAE model of mice.
Sepasi T, Ghadiri T, Ebrahimi-Kalan A, Bani F, Talebi M, Rahbarghazi R, Khodakarimi S, Beyrampour-Basmenj H, Seidi K, Abbaspour-Ravasjani S, Sadeghi MR, Zarebkohan A, Gao H. Sepasi T, et al. Among authors: abbaspour ravasjani s. Int J Pharm. 2023 Apr 5;636:122815. doi: 10.1016/j.ijpharm.2023.122815. Epub 2023 Mar 11. Int J Pharm. 2023. PMID: 36907279
Silencing of HMGA2 by siRNA Loaded Methotrexate Functionalized Polyamidoamine Dendrimer for Human Breast Cancer Cell Therapy.
Abedi Gaballu F, Cho WC, Dehghan G, Zarebkohan A, Baradaran B, Mansoori B, Abbaspour-Ravasjani S, Mohammadi A, Sheibani N, Aghanejad A, Ezzati Nazhad Dolatabadi J. Abedi Gaballu F, et al. Among authors: abbaspour ravasjani s. Genes (Basel). 2021 Jul 20;12(7):1102. doi: 10.3390/genes12071102. Genes (Basel). 2021. PMID: 34356120 Free PMC article.
Corrigendum to "Nanocarrier-based dermopharmaceutical formulations for the topical management of atopic dermatitis" [Int. J. Pharm. 618 (2022) 121656].
Paiva-Santos AC, Gama M, Peixoto D, Sousa-Oliveira I, Ferreira-Faria I, Zeinali M, Abbaspour-Ravasjani S, Mascarenhas-Melo F, Hamishehkar H, Veiga F. Paiva-Santos AC, et al. Among authors: abbaspour ravasjani s. Int J Pharm. 2022 Nov 5;627:122146. doi: 10.1016/j.ijpharm.2022.122146. Epub 2022 Sep 24. Int J Pharm. 2022. PMID: 36167592 No abstract available.
PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy.
Abedi-Gaballu F, Dehghan G, Ghaffari M, Yekta R, Abbaspour-Ravasjani S, Baradaran B, Dolatabadi JEN, Hamblin MR. Abedi-Gaballu F, et al. Among authors: abbaspour ravasjani s. Appl Mater Today. 2018 Sep;12:177-190. doi: 10.1016/j.apmt.2018.05.002. Epub 2018 May 29. Appl Mater Today. 2018. PMID: 30511014 Free PMC article.
16 results